• Explore /
  • Poster
  • / Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer (HER-RAM study).

Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer (HER-RAM study).

Abstract Video & Slides Poster

Authors

Sun Young Rha

Sun Young Rha

Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea

Sun Young Rha , Chang Gon Kim , Minkyu Jung , Hyo Song Kim , Choong-kun Lee , Hei-Cheul Jeung , Dong-Hoe Koo , Woo Kyun Bae , Dae Young Zang , Hyunki Kim , Hyun Cheol Cheol Chung

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4063)

DOI

10.1200/JCO.2021.39.15_suppl.4063

Abstract #

4063

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Sun Young Rha

First Author: Laura Quan Man Chow

First Author: Stacey Stein

First Author: Daniel V.T. Catenacci